Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 9/19/2025

Safety of Combining Vyvanse (Lisdexamfetamine) and Pristiq (Desvenlafaxine)

Pharmacological Considerations

  • Lisdexamfetamine is a prodrug stimulant that is converted to dextroamphetamine after ingestion, used primarily for ADHD treatment 1

Safety Profile of the Combination

  • While neither medication alone significantly increases serotonin syndrome risk, caution should be exercised when combining serotonergic medications, as recommended by the American Academy of Child and Adolescent Psychiatry 2

REFERENCES

1

Placental Transfer of Vyvanse [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025